Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0000 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 06/5/15 All times are local (Market data is delayed by at least 15 minutes).

hard to treat diseases inc (HTDS) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/2/15 - $0.0001
52 Week Low
01/2/15 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

hard to treat diseases inc (HTDS) Related Businessweek News

No Related Businessweek News Found

hard to treat diseases inc (HTDS) Details

Hard to Treat Diseases Inc. is engaged in the export of biological products. The company conducts registrations, carries out clinical trials, and promotes and markets products around the world. It offers vaccines, such as Hepatitis A, Hepatitis B, varicella, poliomyelitis, influenza virus, DTaP combined, meningococcal, rabies, and inactivated Hepatitis A vaccines. The company also provides bio-pharmaceuticals, which include refined tetanus antitoxin, cerebroprotein hydrolysate, urinary kallidinogenase, ulinastatin for injection, HES 130/0.4, lumbrokinase, mycobacterium vaccae for injection, human brain natriuretic peptide, and reteplase (rPA) for injection. In addition, it engages in the registration and sale of MMR vaccines. Hard to Treat Diseases Inc. was founded in 2009 and is based in Shenzhen, China.

hard to treat diseases inc (HTDS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTDS:US $0.00 USD 0.00

HTDS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HTDS.
View Industry Companies

Industry Analysis


Industry Average

Valuation HTDS Industry Range
Price/Earnings 0.6x
Price/Sales 0.1x
Price/Book 0.3x
Price/Cash Flow 0.6x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HARD TO TREAT DISEASES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at